Author:
Nygaard Anneli Dowler,Garm Spindler Karen-Lise,Pallisgaard Niels,Andersen Rikke Fredslund,Jakobsen Anders
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference20 articles.
1. Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer?a review of the literature;Araujo;Oncologist,2007
2. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis;De;Lancet Oncol,2010
3. Roles of EGFR and KRAS mutations in the treatment of patients with non-small-cell lung cancer;Langer;Pharm Ther,2011
4. Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial;Douillard;J Clin Oncol,2010
5. Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS);Fukuoka;J Clin Oncol,2011
Cited by
100 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献